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Differentiating between tuberculosis-related and 
lymphoma-related lymphocytic pleural effusions by  
measuring clinical and laboratory variables: Is it possible?*, **
É possível diferenciar derrames pleurais linfocíticos secundários a 
tuberculose ou linfoma através de variáveis clínicas e laboratoriais?
Leila Antonangelo, Francisco Suso Vargas, Eduardo Henrique Genofre,  
Caroline Maris Neves de Oliveira, Lisete Ribeiro Teixeira,  
Roberta Karla Barbosa de Sales
Abstract
Objective: To describe clinical and laboratory characteristics in patients with tuberculosis-related or lymphoma-
related lymphocytic pleural effusions, in order to identify the variables that might contribute to differentiating 
between these diseases. Methods: This was a retrospective study involving 159 adult HIV-negative patients 
with tuberculosis-related or lymphoma-related lymphocytic effusions (130 and 29 patients, respectively), treated 
between October of 2008 and March of 2010 at the Pleural Diseases Outpatient Clinic of the University of São 
Paulo School of Medicine Hospital das Clínicas Heart Institute, in the city of São Paulo, Brazil. Results: Mean 
age and the mean duration of symptoms were lower in the tuberculosis group than in the lymphoma group. The 
levels of proteins, albumin, cholesterol, amylase, and adenosine deaminase (ADA) in pleural fluid, as well as the 
serum levels of proteins, albumin, and amylase, were higher in the tuberculosis group, whereas serum cholesterol 
and triglycerides were higher in the lymphoma group. Pleural fluid leukocyte and lymphocyte counts were higher 
in the tuberculosis group. Of the tuberculosis group patients, none showed malignant cells; however, 4 showed 
atypical lymphocytes. Among the lymphoma group patients, cytology for neoplastic cells was positive, suspicious, 
and negative in 51.8%, 24.1%, and 24.1%, respectively. Immunophenotyping of pleural fluid was conclusive 
in most of the lymphoma patients. Conclusions: Our results demonstrate clinical and laboratory similarities 
among the patients with tuberculosis or lymphoma. Although protein and ADA levels in pleural fluid tended 
to be higher in the tuberculosis group than in the lymphoma group, even these variables showed an overlap. 
However, none of the tuberculosis group patients had pleural fluid ADA levels below the 40-U/L cut-off point.
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Resumo
Objetivo: Descrever características clínicas e laboratoriais em pacientes com derrames pleurais linfocíticos 
secundários a tuberculose ou linfoma, a fim de identificar as variáveis que possam contribuir no diagnóstico 
diferencial dessas doenças. Métodos: Estudo retrospectivo com 159 pacientes adultos HIV negativos com 
derrame pleural linfocítico secundário a tuberculose ou linfoma (130 e 29 pacientes, respectivamente) tratados 
no Ambulatório da Pleura, Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade 
de São Paulo, São Paulo (SP), entre outubro de 2008 e março de 2010. Resultados: A média de idade e de 
duração dos sintomas foi menor no grupo tuberculose que no grupo linfoma. Os níveis pleurais de proteínas, 
albumina, colesterol, amilase e adenosina desaminase (ADA), assim como os níveis séricos de proteínas, albumina 
e amilase, foram maiores no grupo tuberculose, enquanto os níveis séricos de colesterol e triglicérides foram 
maiores no grupo linfoma. As contagens de leucócitos e linfócitos no líquido pleural foram maiores no grupo 
tuberculose. Células malignas estavam ausentes no grupo tuberculose; entretanto, linfócitos atípicos foram 
observados em 4 desses pacientes. No grupo linfoma, a citologia para células neoplásicas foi positiva, suspeita 
e negativa em 51,8%, 24,1% e 24,1% dos pacientes, respectivamente. A imunofenotipagem do líquido pleural 
foi conclusiva na maioria dos pacientes com linfoma. Conclusões: Nossos resultados demonstram semelhanças 
clínicas e laboratoriais entre os pacientes com tuberculose ou linfoma. Embora os níveis de proteínas e ADA no 
líquido pleural tendam a ser mais elevados no grupo tuberculose que no grupo linfoma, mesmo essas variáveis 
mostraram uma sobreposição. Entretanto, nenhum paciente com tuberculose apresentou níveis de ADA no 
líquido pleural inferiores ao ponto de corte (40 U/L).
Descritores: Derrame pleural; Tuberculose; Linfoma; Adenosina desaminase; Diagnóstico diferencial.
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further complicate the differential diagnosis with 
pleural tuberculosis.
In this context, the objective of the present 
study was to describe clinical and laboratory 
characteristics in patients with tuberculosis-
related or lymphoma-related lymphocytic pleural 
effusions, in order to identify the variables that 
might contribute to differentiating between these 
diseases.
Methods
This was a retrospective study based on 
a database of patients treated at the Pleural 
Diseases Outpatient Clinic of the University 
of São Paulo School of Medicine Hospital das 
Clínicas Heart Institute, located in the city of 
São Paulo, Brazil. The study was approved by 
the University of São Paulo School of Medicine 
Research Ethics Committee. We evaluated the 
medical records of adult HIV-negative patients 
with tuberculosis-related or lymphoma-related 
lymphocytic effusions treated between October 
of 2008 and March of 2010.
The diagnosis of pleural tuberculosis was based 
on the following: clinical history consistent with 
the diagnosis; satisfactory response to specific 
treatment; and positive cultures for M. tuberculosis 
(in sputum, pleural fluid, or tissue specimens) 
or pleural biopsy demonstrating a chronic 
granulomatous process. Lymphomatous pleural 
effusion was characterized by the finding of 
malignant lymphoid cells in pleural fluid or tissue, 
with an immunophenotypic profile consistent 
with monoclonal lymphoproliferative disease, in 
patients with or without a previous diagnosis 
of lymphoma.
In order to determine the clinical, radiological, 
and laboratory characteristics of the patients, the 
following were employed: conventional biochemical 
analyses; determination of ADA levels (by the 
modified Giusti method)(15); microbiological 
tests; cytological/histological examination; and 
lymphocyte immunophenotyping, when necessary.
The statistical analysis was carried out with 
the SigmaStat statistical package, version 3.5 
(Systat Software Inc., San Jose, CA, USA). The 
data are presented as median and interquartile 
range for biochemical and cytological variables 
or as mean and standard deviation for age and 
duration of symptoms. In order to compare 
the groups, we used the t-test or the Mann-
Whitney test, depending on the distribution of 
Introduction
Pleural involvement in infectious, inflammatory, 
or neoplastic diseases almost invariably results in 
accumulation of fluid in the pleural space. In the 
USA, it is estimated that 1.5 million new cases 
of pleural effusion occur every year, including 
transudates due to heart or liver problems.(1) If 
we exclude parapneumonic effusions and acute 
inflammatory exudates, which are generally 
neutrophilic, most of the remaining types of 
effusion are considered lymphocytic (more than 
50% with nucleated cells).(2)
Brazil ranks 19th in terms of tuberculosis 
incidence,(3) and pleural tuberculosis is one of 
the main causes of lymphocytic pleural effusion 
in adults. In such cases, the pleural fluid is an 
exudate with high levels of proteins, adenosine 
deaminase (ADA), and IFN-γ.(4-12)
The methods that are currently used in 
order to diagnose pleural tuberculosis have 
problems, including low positivity rates in the 
direct testing for AFB, low sensitivity (20-30%), 
and delayed Mycobacterium tuberculosis growth 
in pleural fluid cultures. Although the presence 
of granulomas has been demonstrated in up to 
80% of pleural tissue samples,(7-9) pleural biopsy 
is needed in order to establish the diagnosis. 
In this context, the measurement of ADA in 
pleural fluid is an alternative method for the 
diagnosis of tuberculosis, given that the test 
is highly accurate, reproducible, inexpensive, 
user-friendly, and rapid.(11)
If malignancy is suspected, pleural fluid 
cytology is the diagnostic method of choice, the 
sensitivity of the method ranging from 40% to 
87%.(2) Closed pleural biopsy does not significantly 
contribute to the diagnosis of malignancy, given 
that the positivity rates for closed pleural biopsy 
are lower than are those for cytology, ranging 
from 36% to 60%.(2)
Within this scenario, the exudates associated 
with hematologic neoplasms, particularly 
non-Hodgkin’s lymphomas, represent the 
true challenge in the differential diagnosis 
of lymphocytic pleural effusions. Because the 
morphological features of lymphoma subtypes 
vary widely, it is often difficult to detect malignant 
cells in effusions, particularly in cases of low-grade 
lymphocytic lymphomas.(13,14) In some lymphomas, 
in addition to lymphocyte predominance, the 
pleural fluid can show high ADA levels, a finding 
that is uncommon in solid tumors and that can 
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serum levels of cholesterol and triglycerides were 
significantly higher in the lymphoma group.
Regarding the cytological evaluation, the 
proportion of leukocytes and lymphocytes in pleural 
fluid was found to be higher in the tuberculosis 
group (Table 3). Screening for malignant cells 
was carried out in both groups and was found to 
be negative in most of the tuberculosis patients 
(96.9%); however, atypical lymphocytes have 
been found in 4 (3.1%). In those patients, culture 
for M. tuberculosis in pleural fluid or tissue was 
positive, and, during the follow-up period, there 
was a satisfactory response to specific treatment, 
with no evidence of malignancy.
Among the patients with lymphoma-related 
pleural effusions, cytology for malignant cells 
was positive, highly suspicious, and negative in 
51.8%, 24.1%, and 24.1%, respectively. Closed 
pleural biopsy revealed lymphomatous infiltrate 
in 41.4%. In patients with suspicious cytology 
results and negative pleural biopsy, the diagnosis 
of lymphoma was confirmed by histology and 
immunophenotyping of lymphocytes in sites other 
than the pleura. Table 4 shows the histological/
phenotypic classification of the lymphoma cases. 
Effusions associated with Hodgkin’s lymphoma 
accounted for only 6.9% of the cases. In cases 
of effusions associated with non-Hodgkin’s 
lymphoma, B-cell subtypes predominated (66.7%).
the variables. For categorical variables, we used 
the chi-square test. A value of p < 0.05 was 
considered significant.
Results
Table 1 shows the clinical and demographic 
data of the 159 patients (130 patients with 
tuberculosis and 29 patients with lymphoma) 
included in the present study. In both groups, 
there was a slight predominance of males. The 
mean age and the mean duration of symptoms 
were significantly lower in the tuberculosis 
group. Among the symptoms reported, only 
night sweats were significantly more common 
in the tuberculosis group than in the lymphoma 
group. Right pleural effusion predominated, 
regardless of the etiology.
The biochemical variables studied are shown 
in Table 2. The levels of protein, albumin, 
cholesterol, and amylase in pleural fluid were 
significantly higher in the tuberculosis group 
than in the lymphoma group. All of the patients 
in the tuberculosis group and 31% of those in 
the lymphoma group showed pleural fluid ADA 
levels higher than the upper normal limit (40 U/L). 
Serum levels of protein, albumin, and amylase 
were significantly higher in the tuberculosis 
group than in the lymphoma group, whereas 
Table 1 - Demographic, clinical, and radiological data of 159 patients with tuberculosis-related or lymphoma-
related pleural effusions.a
Variable Group p
Tuberculosis Lymphoma
n = 130 n = 29
Male gender 89 (68.5) 15 (51.7) 0.133
Age, yearsb 44.7 ± 17.4 64.1 ± 18.9 < 0.001
Smoking 39 (30) 10 (35) 0.761
Duration of symptoms, monthsb 2.1 ± 3.1 2.9 ± 3.2 0.037
Cough 93 (72) 16 (57) 0.193
Hemoptysis 2 (1.5) 1 (3.5) 0.969
Dyspnea 89 (77) 24 (85) 0.485
Fever 76 (66) 21 (75) 0.473
Chest pain 71 (62) 13 (46) 0.169
Night sweats 69 (60) 9 (28) 0.003
Weight loss 72 (63) 16 (57) 0.696
Pleural effusion
Right 79 (60.7) 15 (51.7) 0.489
Left 50 (38.5) 11 (38.0) 0.538
Bilateral 1 (0.8) 3 (10.3) 0.022
aValues expressed as n (%), except where otherwise indicated. bValues expressed as mean ± SD.
184 Antonangelo L, Vargas FS, Genofre EH, Oliveira CMN, Teixeira LR, Sales RK
J Bras Pneumol. 2012;38(2):181-187
lymphoma group. Biochemical analysis showed 
that protein and ADA levels in pleural fluid 
were higher in the tuberculosis group, lactate 
dehydrogenase having been found to be unable 
to discriminate between the causes of effusion. 
Despite the lymphocytic nature of both diseases, 
the proportion of lymphocytes was found to be 
higher in the tuberculosis group. Pleural biopsy 
was found to play an unquestionable role in 
Discussion
The present study evaluated clinical and 
laboratory characteristics of patients with 
lymphocytic pleural effusions secondary to 
tuberculosis or lymphoma. Although there were 
no differences between the groups in terms of 
the predominance of unilateral effusion, age 
and duration of symptoms were greater in the 
Table 3 - Cytological variables in pleural fluid samples from 159 patients with tuberculosis-related or 
lymphoma-related pleural effusions.a
Variable Group p
Tuberculosis Lymphoma
n = 130 n = 29
Total cells, /mm3 2,700 (1,248-4,380) 2,210 (1,400-5,600) 0.810
Leukocytes, % 91.0 (87.8-95) 82.0 (67.0-90.0) < 0.001
Neutrophils, % 2.0 (1.0-4.0) 4.5 (1.0-13.0) 0.005
Eosinophils, % 0.0 (0.0-1.0) 2.2 (0.0-6.0) 0.020
Lymphocytes, % 96.0 (93.0-98.0) 90.0 (70.0-96.0) < 0.001
Monocytes, % 1.0 (1.0-2.0) 1.0 (1.0-2.0) 0.781
Macrophages, % 7.0 (4.0-10.0) 14.5 (2.0-25.0) 0.070
Mesothelial cells, % 1.0 (0.0-1.0) 1.0 (0.0-5.0) 0.004
aValues expressed as median (interquartile range).
Table 2 - Biochemical variables analyzed in pleural fluid and blood samples from 159 patients with 
tuberculosis-related or lymphoma-related pleural effusions.a
Variable Group p
Tuberculosis Lymphoma
n = 130 n = 29
Pleural fluid
Glucose, mg/dL 70.0 (55.0-82.0) 83.5 (53.0-103.0) 0.053
Protein, g/dL 5.3 (4.9-5.7) 4.1 (2.9-4.4) < 0.001
Albumin, g/dL 2.6 (2.3-3.0) 2.5 (2.0-2.8) 0.018
LDH, U/L 740 (553-952) 561 (355-1,567) 0.454
Cholesterol, mg/dL 85 (70-100) 68.0 (60.0-85.0) 0.008
Triglycerides, mg/dL 31.5 (25.0-40.0) 34.0 (22.0-75.0) 0.289
Amylase, U/L 54 (42-68) 39 (24-57) 0.012
ADA, IU/L 97 (77-128) 66 (41-99) < 0.001
Blood
Glucose, mg/dL 83.0 (73.0-92.0) 83.5 (71.0-98.0) 0.983
Protein, g/dL 7.7 (7.2-8.2) 6.8 (5.5-7.2) < 0.001
Albumin, g/dL 3.7 (3.3-4.1) 3.4 (2.9-3.7) 0.015
LDH, U/L 485 (424-569) 549 (413-1,009) 0.062
Cholesterol, mg/dL 157 (127-184) 190 (160-202) 0.029
Triglycerides, mg/dL 88.0 (68.8-121.0) 123.0 (95.0-173.0) < 0.001
Amylase, U/L 71 (55-91) 39 (24-57) < 0.001
Pleura/blood ratio
LDH 1.69 (1.20-2.20) 0.74 (0.56-1.38) < 0.001
Protein 0.69 (0.65-0.73) 0.61 (0.52-0.69) < 0.001
LDH: lactate dehydrogenase; and ADA: adenosine deaminase. aValues expressed as median (interquartile range).
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mesothelial cells (< 5%).(18) These characteristics 
were found in most of the patients investigated 
in the present study.
Pleural effusion secondary to 
lymphoproliferative diseases constitutes a major 
cause of malignant effusion. According to Sahn,(20) 
lymphoproliferative diseases represent the third 
leading cause of pleural effusion (10%), after 
breast carcinoma and lung carcinoma (25% and 
36%, respectively). Depending on the mechanisms 
involved in pleural fluid formation, the fluid can 
be a transudate or an exudate. In the present 
study, all of the effusions were exudates, with 
a slight increase in the levels of protein and 
lactate dehydrogenase. Although increased 
triglyceride levels in pleural fluid have been 
reported in cases of lymphoma,(13,14,17) only 4 
(≈14%) of the lymphoma patients investigated 
in the present study showed triglyceride levels 
higher than 110 mg/dL, which explains the low 
mean values obtained in that group, as well 
as the absence of statistical significance when 
those values were compared with those obtained 
in the tuberculosis group. Although high levels 
of cholesterol in pleural fluid are associated 
with pseudochylous effusions, a condition 
that is generally associated with chronic fluid 
collections,(21) cholesterol in pleural fluid can 
be used in order to classify pleural exudates. In 
the present study, although cholesterol levels 
were found to be slightly increased in the two 
groups, they were higher in the tuberculosis 
group. Amylase, an enzyme that is increased 
in the pleural fluid of patients with pancreatic 
diseases or rupture of the esophagus, can also 
be moderately elevated in malignant effusions. 
Joseph et al.(22) and Villena et al.(23) reported 
increased amylase levels in patients with lung 
cancer, although a similar finding has also been 
reported in cases of lymphoma and tuberculosis. 
In the present study, 3 (10.3%) of the patients 
with lymphoma and 8 (6.0%) of those with 
tuberculosis had amylase levels in pleural fluid 
that were higher than those considered normal 
in serum.
An enzyme released by activated T lymphocytes 
and macrophages, ADA is considered an important 
biological marker for the diagnosis of pleural 
tuberculosis, especially in countries with a high 
prevalence of the disease. Cut-off points between 
35 and 70 U/L result in sensitivity and specificity 
greater than 80%, with a negative predictive value 
establishing the diagnosis of pleural tuberculosis. 
However, the contribution of pleural biopsy to 
the diagnosis of lymphoma was found to be less 
significant than was that of pleural fluid cytology.
The differential diagnosis between 
lymphomatous pleural effusions and benign 
diseases that progress with lymphocytic pleural 
effusion is generally difficult, given that the pleural 
fluid displays few monomorphic lymphoid cells 
with few morphological changes in both situations.
(14,16-18) In addition, ADA levels are commonly 
increased in the pleural fluid of patients with 
lymphoma, regardless of the cell subtype (T or 
B cells).(13)
From a clinical standpoint, both tuberculosis 
and lymphoma predominate in males in the 
second decade of life, although tuberculosis can 
also affect younger patients.(7,17-19) The clinical 
similarities between tuberculosis patients and 
lymphoma patients are noteworthy. In both types 
of patients, complaints are usually related to the 
magnitude of the effusion and to constitutional 
symptoms, such as weight loss.(7,18,19)
Although dry cough, pleuritic chest pain, 
and fever were more commonly reported by the 
patients with tuberculosis, those symptoms were 
also common in those with lymphoma. Night 
sweats, a common symptom in patients with 
pulmonary tuberculosis,(18) were found to be 
significantly more common in the patients with 
pleural tuberculosis (60%).
In patients with pleural tuberculosis, cytology 
typically reveals a predominance of mature 
lymphocytes (> 50%), together with scarce 
Table 4 - Classification and diagnostic frequency of 
non-Hodgkin’s lymphoma cases.a
Classification Non-Hodgkin’s 
lymphoma
(n = 27)
B cells 18 (66.7)
Diffuse large B cells 6 (22.2)
Lymphocytic 4 (14.8)
Follicular 2 (7.4)
Burkitt 2 (7.4)
Lymphoplasmacytic 2 (7.4)
Primary effusion lymphoma 2 (7.4)
B- and T-cell precursors 
(lymphoblastic)
9 (33.3)
aOf the 29 cases evaluated, only 2 were diagnosed as 
Hodgkin’s lymphoma.
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of mature B-cell lymphomas, which are easily 
identified by that method.
In conclusion, our results reinforce that patients 
with tuberculosis-related pleural effusion and 
those with lymphoma-related pleural effusion 
have similar clinical, radiological, and laboratory 
characteristics. Although protein and ADA 
levels in pleural fluid tended to be higher in 
the tuberculosis group than in the lymphoma 
group, even these variables showed an overlap. 
However, it should be highlighted that none 
of the tuberculosis patients investigated in the 
present study had pleural fluid ADA levels below 
the 40-U/L cut-off point.
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